Article Details
Retrieved on: 2022-09-14 04:17:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca announced updated results from the TOPAZ-1 Phase III trial showed AstraZeneca's IMFINZI(R) (durvalumab), in combination with ...
Article found on: simplywall.st
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here